EpilepsyGTx, a Cambridge-based BioTech startup focapplyd on research and development of gene therapies to treat refractory epilepsy, today announced it…
Read More

EpilepsyGTx, a Cambridge-based BioTech startup focapplyd on research and development of gene therapies to treat refractory epilepsy, today announced it…
Read More